Immune response to Covid-19 vaccination in patients with immune modulatory treatment for cancer
Latest Information Update: 09 Apr 2021
At a glance
- Drugs AZD 1222 (Primary) ; Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- Acronyms CoVaCan
- 09 Apr 2021 New trial record